American heart journal · 2026
Design and rationale of the TANGO2 trial: A randomized controlled non-inferiority trial of bystander compression-only CPR versus standard CPR in out-of-hospital cardiac arrest.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boberg Erik, Merigo Giulia, Riva Gabriel, Ringh Mattias, Ristagno Giuseppe, Jonsson Martin, Nordius Cecilia, Magliocca Aurora, Skrifvars Markus B, Byrsell Fredrik, Jonsson Fredrik, Claesson Andreas, Svensson Leif, Nordberg Per, Nord Annette, Hollenberg Jacob
Аннотация
RATIONALE: Bystander cardiopulmonary resuscitation (CPR) before emergency medical services arrival is associated with improved survival after out-of-hospital cardiac arrest (OHCA). Compression-only CPR (CO-CPR) is simpler to teach and perform, eliminates interruptions in chest compressions for rescue breaths, and has been associated with higher bystander CPR rates. For adults with OHCA of presumed medical etiology, clinical equipoise remains regarding the optimal CPR strategy for previously trained bystanders.
PRIMARY HYPOTHESIS: Bystander CO-CPR is non-inferior to standard CPR (S-CPR) for 30-day survival in dispatch-assisted out-of-hospital cardiac arrest DESIGN: TANGO2 is an international, multicenter, randomized, open-label, non-inferior trial. Dispatchers randomize eligible cases 1:1 to CO-CPR or S-CPR via an integrated decision-support system. Protocol adherence is evaluated via systematic dispatch audio review. Per-protocol (PP) analysis is prespecified as the primary analysis, supported by modified intention-to-treat (mITT) analysis. Non-inferiority is defined as an absolute risk difference above -1.0 percentage points.
SITES: All Emergency Medical Dispatch Centers in Sweden and selected sites in Italy.
ESTIMATED ENROLLMENT: 3,260 per-protocol EMS-treated OHCA patients ENROLLMENT DATES: Start date: 2017. Estimated completion date: December 2027.
CURRENT STATUS: Enrolling.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03981107, https://clinicaltrials.gov/study/NCT03981107.
PRIMARY HYPOTHESIS: Bystander CO-CPR is non-inferior to standard CPR (S-CPR) for 30-day survival in dispatch-assisted out-of-hospital cardiac arrest DESIGN: TANGO2 is an international, multicenter, randomized, open-label, non-inferior trial. Dispatchers randomize eligible cases 1:1 to CO-CPR or S-CPR via an integrated decision-support system. Protocol adherence is evaluated via systematic dispatch audio review. Per-protocol (PP) analysis is prespecified as the primary analysis, supported by modified intention-to-treat (mITT) analysis. Non-inferiority is defined as an absolute risk difference above -1.0 percentage points.
SITES: All Emergency Medical Dispatch Centers in Sweden and selected sites in Italy.
ESTIMATED ENROLLMENT: 3,260 per-protocol EMS-treated OHCA patients ENROLLMENT DATES: Start date: 2017. Estimated completion date: December 2027.
CURRENT STATUS: Enrolling.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03981107, https://clinicaltrials.gov/study/NCT03981107.